Introduction
Hypopharyngeal squamous cell cancer (HSCC) is a rare malignancy accounting for approximately 0.5% of all human malignancies and representing about 3% to 5% of all head and neck cancers (Hoffman et al. 1998) (Cooper et al., 2009 ). Most patients with HSSC share a common history of tobacco and/or alcohol abuse. Despite improvements in surgical and chemoradiation approaches, most patients received an initial diagnosis in the advanced cancer stage, which results in high mortality.
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Jun-Xi Wang, Ying-Yao Zhang, Xue-Min Yu, Tong Jin, Xin-Liang Pan* segregation. They have a role in chromosomes separating from each other and control the cell cycle during mitosis (Sugata et al., 1999) . Kinetochores comprise facultative and constitutive kinetochore proteins. The constitutive kinetochore, centromere protein H (CENP-H), a coiledcoil structural and a nuclear signal protein, plays a crucial role in kinetochore organization and function throughout the whole cell cycle (Cleveland et al., 2003) . Along with other members, CENP-H forms a functional complex required for faithful chromosome segregation (Sugata et al., 2000; Okada et al., 2006) . Furthermore, knockdown of CENP-H led to severe mitotic phenotypes and reduced CENP-C level, which suggests that CENP-H plays an important role in the architecture and function of the kinetochore complex (Orthaus et al., 2006) . The expression of CENP-H was found upregulated in malignant tumors such as colorectal cancer (Tomonaga et al., 2005) . CENP-H may be relevant in tumorigenesis and a promising prognostic marker in non-small cell lung cancer, esophageal carcinoma, oral squamous cell car cinoma, and nasopharyngeal carcinoma (Shigeishi et al., 2006; Liao et al., 2007; 2009; Guo et al., 2008) . However, the involvement of CENP-H as a relapse-associated biomarker in HSCC has not been clarified.
Ki67 is strongly expressed in proliferating cells and universally accepted as a proliferation marker, because it is present in all active phases but not the resting phase (G0) of the cell cycle during mitosis (Gerdes et al., 1983) (Scholzen et al., 2000) . Ki67 has been widely studied and used in various fields. It has been used to predict survival and relapse in oral carcinoma (Wangsa et al., 2008; Faratzis et al., 2009) .
We aimed to investigate the role of CENP-H and Ki67 in HSCC and an association with relapse-free survival after curative resection.
Materials and Methods
Patients and specimens
We Cancer tissues were immersed in 10% neutral buffered formalin immediately after resection, then embedded in a paraffin block. As well, fresh cancer and matched normal epithelia specimens from HSCC patients were frozen in liquid nitrogen, then stored at -80 ℃.
Postoperative follow-up
After resection, follow-up included history taking and physical examination, as well as electronic laryngoscopy every 3 months. Patients underwent CT or MRI every 8 months to identify relapse or not. Relapse-free survival was defined as the interval between the date of surgery and the date of diagnosis of relapse. Follow-up and faceto-face conversation with patients and/or relatives was over 15 min. The follow-up ended April 2010. The median follow-up was 48.5 months (range 2-73 months).
Antibodies
CENP-H and Ki67 antibodies were from Bethyl Laboratories (1:75 dilution, Montgomery, TX, USA) and Zhongshan Golden Bridge Biotechnology (Beijing; working solution), respectively.
Immunohistochemistry and evaluation
Immunohistochemistry of CENP-H and Ki67 expression involved tissue sections (4-µm) deparaffinized and rehydrated. Epitopes were retrieved by microwaving at 750W for 20 min in EDTA (pH 8.0) buffer to enhance immunoreactivity. After blocking the endogenous peroxidase activity with 3% H 2 O 2 for 10 min and nonspecific antibody reaction with 5% normal goat serum for 20 min at room temperature, sections were incubated with primary antibodies overnight at 4 ℃. Negative control sections were incubated with phosphate buffered saline (PBS) instead of primary antibodies. Antibody binding was detected with use of the avidinbiotin complex histofine universal kit (Zhongshan Golden Bridge Biotechenology) and visualized by the 3.3'-diaminobenzidine method for 5 min. Sections were then counterstained with Meyer's haematoxylin. Labeled nuclei were reported as percentage of total tumor cells counted and graded as 0 (negative staining); 1 + (low staining or < 20%); 2 + (intermediate staining or 20-50%); and 3 + (strong staining or > 50%). 0 and + were considered low and 2+ and 3+ high expression.
Cell lines and culture
The FaDu HSCC cell line (ATCC) and its derived lines (ATCC) were cultured as routine with RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) at 37 ℃ in 5% CO 2 -humidified incubators with subculture every 3 days.
Knockdown of CENP-H in cells
P r i m e r s e q u e n c e s f o r s m a l l i n t e r f e r i n g R N A ( s i R N A ) f o r C E N P -H w e r e f o r w a r d ,
Negative scramble control sequences were forward, 5'-UUCUCCGAACGUGUCACGUTT-3' and reverse, 5'-ACGUGACACGUUCGGAGAATT-3 (Shanghai GenePharma). Transient transfection of siRNA in cells involved the Lipofectamine 2000 method (Invitrogen). Transfection efficiency was detected by western blotting.
Western blot analysis
Harvested cells were lysed with ice-cold lysis buffer. Protein samples were seperated by electrophoresis in an 10% denature polyacrylamide gel, transferred to PVDF membranes (Immoblelon-p, Millipore, Bedford, USA), and were probed with antibodies. Proteins were visualized by enhanced chemiluminescence (ECL) western Blotting Detection Reagents (Millipore, Bedford, MA, USA).
Flow cytometry
At 48 hr after transfection, cells were harvested and centrifuged, then washed twice with PBS and stained with 50 μg propidium iodide and 100 μg annexin-V. Flow cytometry involved use of the Apoptosis Assay kit (Roche).
Cell proliferation assay
Cell growth was assessed by cholecystokinin octapeptide (CCK-8) assay. At 24, 48, and 72 hr after siRNA transfection, cells (5×10 3 ) were seeded into 96-well plates, and 10 µl CCK-8 (Cell Counting Kit; Bestbio, China) was added in each well for incubation at 37 ℃ for 1.5 hr. The optical density (OD) was measured at 450 nm for each well by use of a microplate reader (Bio-Rad Model 680, Richmond, CA, USA).
Statistical analysis
Statistical analysis involved use of SPSS v16.0 
Results
CENP-H and Ki67 expression and their association with HSCC
CENP-H and Ki67 protein immunostaining was mainly observed in nuclei of HSCC cells of the 112 specimens (Figure 1 ): 50 cases (44.6%) showed upregulated CENP-H expression (62 specimens showed low CENP-H expression) and 69 cases (61.6%) showed upregulated Ki67 overexpression. CENP-H expression was associated with Ki67 expression (P= 0.005).
Association of CENP-H and Ki67 expression with clinicopathologic features
CENP-H overexpression was associated with the advanced cancer stage (P = 0.012) and alcohol consumption (P = 0.048) (Table 1 ), but Ki67 overexpression was associated with only advanced cancer stage (P=0.021).
Association of CENP-H and Ki67 expression with relapsefree survival
Patients were stratified by low and high protein expression to determine whether CENP-H and Ki67 expression were related to patient relapse-free survival. By Kaplan-Meier survival analysis, relapse-free survival was shorter for patients with than without CENP-H and Ki67 overexpression (P<0.001 and P = 0.009, respectively (Figure 2 ). Multivariate analysis confirmed CENP-H and Ki67 overexpression as independent predictors of relapsefree survival (P = 0.001 and P = 0.018, respectively) ( Table  2 ).
Role of CENP-H in HSCC apoptosis
CNPH protein was markedly downregulated after CENP-H siRNA transfection in HSCC cells at 48 hr ( Figure 3A) . We determined whether siRNA knockdown of CENP-H induced cell apoptosis by FACS analysis. siRNA knockdown of CENP-H protein level greatly increased apoptosis as compared with controls (P<0.01) ( Figure 3B ), which indicates that CENP-H overexpression in HSCC might promote cancer cell proliferation by inhibiting cell apoptosis.
Role of CENP-H in HSCC cell proliferation
CCK-8 assay was used to measure HSCC cellular proliferation after siRNA knockdown of CENP-H. Cellular proliferation was decreased with CENP-H siRNA knockdown in HSCC cells at 48 and 72 hr (P<0.01) ( Figure 3C) , so CENP -H overexpression in HSCC may be involved in cancer cell proliferation.
Discussion
Centromere and kinetochore proteins play a pivotal role in accurate chromosome segregation. However, the underlying mechanism is not fully understood. Centromere fission can result in chromosomal instability and generate aneuploid because of defects (Martinez et al., 2011) . Aneuploidy may induce tumorigenesis (Duesberg et al., 2000; Duesberg et al., 2003; Bharadwaj et al., 2004) . Previous studies found abnormal phenotypes in chicken DT40 cells after CENP-H knockdown (Fukagawa et al., 2000; Mikami et al., 2005 ). Deletion of CENP-H in zebra fish could upregulate components of the intrinsic apoptotic pathway, thus reducing tumorigenesis (Zhao et al., 2010) . However, no study has examined CENP-H expression or its association with relapse-free interval in patients undergoing curative resection for HSCC. Previous study found CENP-H overexpressed in primary colorectal cancer at both protein and mRNA levels (Tomonaga et al., 2005) . In this study, we found CENP-H protein level upregulated in 112 specimens of HSCC and associated with advanced cancer stage and alcohol consumption. Thus, CENP-H overexpression may be involved in HSCC progression and play an important role in tumorigenesis. Previous studies showed CENP-A and CENP-F associated with epithelium-originated malignancies (Guardia et al., 2001; Tomonaga et al., 2003; O'Brien et al., 2007) . Kinetochore protein activity may be altered in some epithelial malignancies. The overexpression of CENP-H in HSCC prompted us to evaluate the relationship between its protein expression and relapse-free survival. We found an association of CENP-H overexpression associated with poor relapse-free survival in HSCC, which suggests that CENP-H may play a critical role in increasing the risk of tumor relapse.
Compared to CENP-H, Ki67 was more commonly expressed in our HSCC samples. We found a significant association of Ki67 expression and cancer stage but not other factors. These results are not consistent with previous studies (Faratzis et al., 2009 ) and may relate to differences in epithelial malignancy and patient population. In agreement with previous findings (Shigeishi et al., 2006; Liao et al., 2009 ), we found a significant association of increased CENP-H and Ki67 protein expression, probably in part because of the role of CENP-H in promoting tumor cell proliferation. We also found increased Ki67 protein expression associated with poor relapse-free survival in patients with HSCC. Furthermore, increased CENP-H and Ki67 protein expression were independent prognostic factors of survival. In our study, patients with HSCC showed high risk of relapse after primary surgery or surgery and radiation. However, the current technology cannot completely determine early occult relapse without histopathological evaluation, so some patients cannot be treated because of delay in diagnosis. Immunohistochemical tumor markers, as well as CENP-H and Ki67 expression analysis, may help predict the risk of relapse after treatment.
Knockdown of CENP-H in HSCC cells induced cell apoptosis and impaired cell proliferation, which suggests that CENP-H may have an important role in HSCC cell proliferation and may explain the association of increased CENP-H expression with high relapse rate after curative resection. Limitless replicative potential is an important feature of malignant tumors and the most important biological mechanisms in oncogenesis (van Diest et al., 1998; Hanahan et al., 2000) . Tumor growth strongly depends on the balance between proliferation and apoptosis. Our findings can point to new therapeutic strategies based on regulating CENP-H or Ki67 activity, because surgery and/or radiation therapy often fail to prevent tumor relapse.
The strengths of our study are that we excluded patients with preoperative radiotherapy and/or chemotherapy and the edges of resection were confirmed to be negative by routine histologic examination. Also, our study featured adequate follow-up and face-to-face conversation with patients and/or relatives to obtain detailed information. However, our sample size was small, and the results need to be confirmed in a larger popoulation.
In conclusion, our study demonstrated that increased CENP-H protein expression was common in HSCC and significantly associated with increased Ki67 protein expression. In addition, both CENP-H and Ki67 protein overexprssion was significantly associated with short relapse-free survival. CENP-H and Ki67 protein expression may have clinical potential for adjuvant therapy as indicators of cancer-associated survival after resection. Although our results are promising, future study is required to investigate the mechanism underlying the role of CENP-H in promoting tumor growth and in prognosis.
